Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Dermatology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Dermatology Other
    Study: American Physicians Lack Understanding of Patients' Health Beliefs - (DGNews)
    Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study - (BMJ)
    Study Suggests Link Between Scleroderma, Cancer in Certain Patients - (DGNews)
    Retinoid Use Not Associated With Fracture Risk - (DGNews)
    Alitretinoin Approved in Italy for Severe Chronic Hand Eczema - (DGNews)

    News archive

     Recent webcasts/CME - Dermatology Other
      Non- STD Dermatological Manifestations
      Skin Cancer Update
      Tuberous Sclerosis
      Advances in the Treatment of Actinic Keratosis: Evidence-Based Approaches for Optimized Outcomes
      The Prevention and Treatment of Pressure Ulcers

      Webcasts/CME archive

       Recent cases - Dermatology Other
        Cutaneous Larva Migrans With Optic Disc Edema: A Case Report
        Severe Leukocytoclastic Vasculitis Secondary To The Use Of A Naproxen And Requiring Amputation: A Case Report
        Unusual Presentation Of Cactus Spines In The Flank Of An Elderly Man: A Case Report
        Multifocal Stevens-Johnson Syndrome After Concurrent Phenytoin And Cranial And Thoracic Radiation Treatment, A Case Report
        An Erythematous Plaque On The Arm

        Cases archive
          




        my personal edition > dermatology other > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        New MetroGel(R) 1% Kit Provides Convenient Treatment and Added-Value For 14 Million American Sufferers

        FORT WORTH, TX -- January 12, 2007 -- Galderma Laboratories, L.P. today announced the availability of a new MetroGel(R) 1% Kit for the topical treatment of the inflammatory lesions of rosacea. The new kit contains a 60 gm tube of the leading topical prescription treatment for Rosacea, MetroGel(R) (metronidazole) Topical Gel, 1%.

        Also included in the kit is a complimentary 4 fl. oz. bottle of Cetaphil(R) Gentle Skin Cleanser, the number-one skin cleanser recommended by dermatologists, plus a patient education brochure with information about rosacea trigger factors, symptoms and treatment. The brochure contains a $2.00-off coupon for future purchases of Cetaphil(R) brand cleansers and moisturizers.

        MetroGel(R) 1% Kit, with its additional contents, is the same cost as a regular 60gm tube of MetroGel(R) 1%, and the MetroGel(R) 1% Kit is currently available to rosacea patients in pharmacies nationwide. "This is a natural extension for our MetroGel(R) brand franchise. The combination of proven, effective treatments and patient education provides additional value to the patient," said Albert Draaijer, President of Galderma Laboratories, L.P.

        MetroGel(R) 1%, incorporates a vehicle containing HSA-3(TM), a combination of niacinamide, betadex and propylene glycol. The vehicle is a water-based formulation and contains no alcohol. The product requires once-a-day dosing as opposed to twice-a-day for most other topical rosacea treatments.

        According to a study published in the April 2006 issue of Cutis, "A good skin care regimen is a critical part of rosacea treatment, but care must be taken to choose products that do not irritate as rosacea patients typically have sensitive skin."(1) Cetaphil(R) Gentle Skin Cleanser is specifically formulated for dry, sensitive or compromised skin and will not strip the natural protective oils or emollients, or disturb the skin's natural pH balance.

        "The beneficial effect of Cetaphil(R) Cleanser for the sensitive skin of rosacea patients has been verified in clinical trials. Combining MetroGel(R) 1% and Cetaphil(R) Cleanser in a Kit at no additional cost is of substantial value-and provides automatic convenience for rosacea patients," said Dr. James Del Rosso, a dermatologist practicing in Las Vegas, Nevada. (Personal Communication)

        An estimated 14 million Americans suffer from rosacea, characterized by redness, flushing and blushing on the face. However, many people in the early stages of rosacea mistake their symptoms for sunburn, rash or acne, causing them to delay diagnosis and treatment. The chronic disorder primarily affects the cheeks, chin, nose and forehead. Unfortunately, without treatment, rosacea can worsen over time, with the initial redness worsening and becoming more persistent. Visible blood vessels may appear, bumps and pimples may form on the face, eyes may appear to be bloodshot, and eventually, excess tissue may develop on the nose. Recent surveys reveal that almost 70 percent of rosacea patients suffer socially and that their self-esteem is affected by the condition.(2)

        The following adverse experiences have been reported with the topical use of metronidazole: burning, skin irritation, dryness, transient redness, metallic taste, tingling or numbness of extremities, and nausea.

        REFERENCES:
        1. Draelos, Zoe D. The Effect of Cetaphil Gentle Skin Cleanser on the Skin Barrier of Patients With Rosacea. Cutis. 2006;77:27-33.
        2. What is Rosacea?, 2006, Rosacea.org: The National Rosacea Society. http://www.rosacea.org/index.php


        SOURCE: Galderma Laboratories, L.P.



        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send